A new approach in fighting emerging zoonoses’.
The Central Veterinary Institute (CVI), a division of Wageningen UR, is a leading research institute in the field of animal health and infectious diseases. As a non-profit research organisation, the institute serves both public and private goals. Business development manager, Vincent Rijsman, has a pivotal role in generating business and funding for socially relevant fundamental and practical research.
At CVI, research into animal health and infectious diseases is increasingly interconnected with human health. ‘Over the past few years, our focus has shifted from diseases like hoof- and mouth disease and Classical swine fever to emerging zoonoses (diseases transmissible from animals to humans) and antibiotic resistance’, Rijsman explains.
As a founding partner of Immuno Valley, CVI favours public-private partnerships for research & development and supports the One Health approach. ‘The Castellum program is exemplary for such cooperation as we are working in partnership with Utrecht University, RIVM and MSD Animal Health on the testing and development of vaccines. The program operates at the interface of human and animal health and aims to prevent the further spread of emerging zoonoses in animal populations, a completely new and promising approach’, Rijsman says.
As from July 2013, Vincent Rijsman has joined the Faculty of Veterinary Medicine of Utrecht University as a Business Development Director.
A new approach in fighting emerging zoonoses’.The Central Veterinary Institute (CVI), a division of Wageningen UR, is a leading research institute in the field of animal health and infectious diseases. As a non-profit research organisation, the institute serves both public and private goals. Business development manager, Vincent Rijsman, has a pivotal role in generating business and funding for socially relevant fundamental and practical research.At CVI, research into animal health and infectious diseases is increasingly interconnected with human health. ‘Over the past few years, our focus has shifted from diseases like hoof- and mouth disease and Classical swine fever to emerging zoonoses (diseases transmissible from animals to humans) and antibiotic resistance’, Rijsman explains.As a founding partner of Immuno Valley, CVI favours public-private partnerships for research & development and supports the One Health approach. ‘The Castellum program is exemplary for such cooperation as we are working in partnership with Utrecht University, RIVM and MSD Animal Health on the testing and development of vaccines. The program operates at the interface of human and animal health and aims to prevent the further spread of emerging zoonoses in animal populations, a completely new and promising approach’, Rijsman says.As from July 2013, Vincent Rijsman has joined the Faculty of Veterinary Medicine of Utrecht University as a Business Development Director.
การแปล กรุณารอสักครู่..

A new approach in fighting emerging zoonoses’.
The Central Veterinary Institute (CVI), a division of Wageningen UR, is a leading research institute in the field of animal health and infectious diseases. As a non-profit research organisation, the institute serves both public and private goals. Business development manager, Vincent Rijsman, has a pivotal role in generating business and funding for socially relevant fundamental and practical research.
At CVI, research into animal health and infectious diseases is increasingly interconnected with human health. ‘Over the past few years, our focus has shifted from diseases like hoof- and mouth disease and Classical swine fever to emerging zoonoses (diseases transmissible from animals to humans) and antibiotic resistance’, Rijsman explains.
As a founding partner of Immuno Valley, CVI favours public-private partnerships for research & development and supports the One Health approach. ‘The Castellum program is exemplary for such cooperation as we are working in partnership with Utrecht University, RIVM and MSD Animal Health on the testing and development of vaccines. The program operates at the interface of human and animal health and aims to prevent the further spread of emerging zoonoses in animal populations, a completely new and promising approach’, Rijsman says.
As from July 2013, Vincent Rijsman has joined the Faculty of Veterinary Medicine of Utrecht University as a Business Development Director.
การแปล กรุณารอสักครู่..
